Exploring the Feasibility of Long-Acting Cabotegravir/Rilpivirine for Thai Youth living with HIV through the national registry database in Thailand

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20250316001

Enrollment

14670

Registered

2025-03-16

Start date

2024-08-15

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Youth living with HIV who registered in Thai National AIDS Program Long-acting antiretroviral therapy, HIV, cabotegravir, rilpivirine, eligibility, adolescents, young adult

Interventions

Youth living with HIV who registered in national AIDS program of Thailand, aged 12-24 years with at least one HIV RNA PCR testing after 6 months of ART initiation.

Health Services Research

Thai youth living with HIV who registered in national AIDS treament program

Eligibility

Sex/Gender

All

Age

12 Years to 24 Years

Inclusion criteria

Inclusion criteria: 1. Youth living with HIV who registered in national AIDS program of Thailand 2. Aged 12-24 years 3. Documented at least one HIV RNA PCR testing after 6 months of ART initiation

Exclusion criteria

Exclusion criteria: 1. Pregnancy 2. Deceased or lost to follow-up for more than one year

Design outcomes

Primary

Measure	Time frame
Proportion of youth with HIV who were medically eligible to long-acting cabotegravir/rilpivirien As of August 2024 percentage	—

Secondary

Measure	Time frame
Demographic data As of August 2024 proportion	—

Countries

Thailand

Contacts

Public ContactPunnathorn Auabonkanok

Faculty of Medicine, Chulalongkorn University

punnathorn.au@gmail.com022564475

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026